XRF Scientific (XRF) H2 2025 earnings summary

Executive summary

• Achieved record full-year revenue of $59.5m and net profit after tax up 17% to $10.4m year-over-year.

• Strong international sales growth in Asia, the Americas, and Europe, driven by mining sector demand.

• Recurring revenue increased from consumables and platinum labware recycling, supported by a successful cross-selling strategy.

Financial highlights

• Net cash inflow from operating activities reached $10.1m for the year.

• June Q4 delivered record quarterly revenue of $16.8m and profit before tax of $4.3m.

• Final fully franked dividend of 4.5 cents per share, up 15% from last year, with a payout ratio of 61%.

Outlook and guidance

• Continued growth expected from recurring consumable sales and international expansion, particularly in mining.

• Ongoing cross-selling and product diversification strategies to support future performance.